Market Research Logo

Global Constipation Market Report: 2016 Edition

1. Market Overview
1.1 Introduction
1.2 Types
1.2.1 Chronic Idiopathic Constipation (CIC)
1.2.2 Irritable Bowel Syndrome with Constipation (IBS-C)
1.2.3 Opioid-Induced Constipation (OIC)
1.3 Etiology/ Causes
1.3.1 Extrinsic Causes
1.3.2 Intrinsic Causes
1.4 Treatment Options
1.4.1 Pharmacological Treatment
1.4.2 Non Pharmacological Treatments
Table A: Current Treatment Options for Constipation
2. Constipation Market Analysis
2.1 The U.S.
2.1.1 The U.S. Constipation Market by Value
Table 1: The U.S. Constipation Market by Value (2011-2014)
2.1.2 The U.S. Constipation Market Value by Type
Table 2: The U.S. Constipation Market Value by Type (2011-2014)
2.1.3 The U.S. Constipation Market by Volume
Table 3: The U.S. Constipation Market by Volume (2012-2014)
2.1.4 The U.S. Constipation Market Volume by Type
Table 4: The U.S. Constipation Market Volume by Type (2012-2014)
2.1.5 The U.S. Constipation Market by Drug Type
Table 5: The U.S. Constipation Prescription Market by Drug Type (2015E)
2.1.6 The U.S. Constipation Market by Drug
Table 6: The U.S. Amitiza Drug Market by Value (2015E-2020E)
Table 7: The U.S. Plecanatide Drug Market by Value (2017E-2025E)
Table 8: The U.S. Plecanatide Penetration Rate by Type (2017E-2025E)
2.2 Japan
2.2.1 Japan’s Constipation Market by Volume
Table 9: Japan’s Constipation Market by Volume (2015E-2025E)
2.2.2 Japan’s Constipation Drug Market
Table 10: Japan’s Amitiza Drug Market Revenue and Penetration (2015E-2021E)
2.3 China
Table 11: China’s Constipation Market by Volume (2015E-2025E)
3. Chronic Constipation Market Analysis
3.1 The U.S. Chronic Constipation Market by Volume
Table 12: The U.S. Chronic Constipation Market by Volume (2014-2025E)
3.2 European Chronic Constipation Market by Volume
Table 13: European Chronic Constipation Market by Volume (2014-2025E)
4. Irritable Bowel Syndrome Market Analysis
4.1 The U.S. IBS-C Market by Volume
Table 14: The U.S. IBS-C Market by Volume (2014-2025E)
4.2 European IBS-C Market by Volume
Table 15: European IBS-C Market by Volume (2014-2025E)
5. Opioid Induced Constipation Market Analysis
5.1 The U.S. Opioid Induced Constipation Market by Volume
Table 16: The U.S. Opioid Induced Constipation Market by Volume (2015-2025E)
5.1.1 The U.S. Opioid Induced Constipation Drugs Market
Table 17: The U.S. Dolcanatide Market by Value (2019E-2025E)
5.2 European Opioid Induced Constipation Market by Volume
Table 18: European Opioid Induced Constipation Market by Volume (2015-2025E)
5.2.1 European Opioid Induced Constipation Drug Market
Table 19: European Dolcanatide Market by Value (2020E-2027E)
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Consumption of Prescription Opioid Drugs in the U.S.
Table 20: Growing Prescription Opioid Drugs in the U.S. (2000-2014E)
6.1.2 Growing Ageing Population
Table 21: Global Ageing Population Over 65 (2009-2014)
6.1.3 Vast Opportunity with Significant Potential in the U.S.
Table 22: The U.S. Constipation Market by Branded/Non-Branded Therapy (2014)
Table 23: The U.S. Constipation Market by Therapy (2015E-2020E)
6.1.4 Global Spending on Medicines
Table 24: Global Spending on Medicines (2010-2020E)
6.1.5 Growing Female Population
Table 25: Global Female Population (2010-2014)
6.1.6 Rising Healthcare Expenditure
Table 26: Global Healthcare Expenditure Per Capita (2009-2014E)
6.2 Key Trends
6.2.1 Drugs under Development for Constipation
Table B: Pipeline Drugs under Development for Constipation
6.2.2 Market Opportunity for Pediatric Constipation
Table C: Opportunity in Pediatric & Elderly Constipation
6.3 Challenges
6.3.1 Rising Tide of Over-The-Counter Drugs for Constipation
Table 27: Global OTC Market CAGR Growth Rate (2011-2016)
6.3.2 Low Awareness of Prescription Medications for OIC
Table 28: Awareness of OIC Prescription Medications among Patients (2015)
7. Competitive Landscape
Table C: Global Constipation Competitors Comparison
8. Company Profiles
8.1 Sucampo Pharmaceuticals, Inc.
8.1.1 Business Overview
Table 29: Sucampo Revenue by Geographical Segments (2013/2014)
8.1.2 Financial Overview
Table 30: Sucampo Revenue and Net Income (2010-2014)
8.1.3 Business Strategies
Table D: Near-Term Clinical Pipelines of Sucampo
8.2 Synergy Pharmaceuticals, Inc.
8.2.1 Business Overview
Table E: Synergy Pharmaceuticals Clinical-Stage Pipelines
8.2.2 Financial Overview
Table 31: Synergy Pharmaceuticals Revenue and Net Income (2014-2018E)
8.2.3 Business Strategies
Table 32: Synergy’s Research and Development Expenditure (2011-2015)
8.3 AstraZeneca
8.3.1 Business Overview
Table 33: AstraZeneca Revenue by Therapeutic Segment (2015)
8.3.2 Financial Overview
Table 34: AstraZeneca Revenue by Regions (2015)
8.3.3 Business Strategies
Table 35: AstraZeneca Revenue and Net profit (2010-2015)
8.4 Ironwood Pharmaceuticals
8.4.1 Business Overview
Table F: Ironwood Pharmaceutical’s GI and Vascular/Fibrotic Platforms
8.4.2 Financial Overview
Table 36: Ironwood’s Revenue* and Net Loss (2011-2015)
8.4.3 Business Strategies

Global Constipation Market Report: 2016 Edition

Constipation is a common medical condition common among elderly and women, and is interpreted differently by patients and physicians. Constipation can be chronic, sometimes severe, and has a significant, even deliberating effect on the quality of life of a patient. Various treatment options are available for the treatment of constipation and patients often adopt different over-the-counter remedies for the same. There exist three main types of constipation including Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome (IBS-C) and Opioid Induced Constipation (OIC).

There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.

Growth of the constipation market is driven by several factors including rising prescription opioid consumption, growing ageing population, vast opportunity for drugs with significant potential in the U.S., rising spending on medicines, growing female population and rising healthcare expenditure. However, the growth of the market can be hindered by certain challenges including rising tide of OTC drugs for constipation and lower awareness of prescription medication for OIC.

The report, “Global Constipation Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S. Japan China and Europe are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;